Continuous vs intermittent treatment with triple nuke combination of AZT/3TC/tenofovir in Africa: early results from DART study
14 September 2005. Related: Conference reports, Treatment access.
2005
Global Fund commitment to $175M annually in 2006, 2007
14 September 2005. Related: Treatment access.
UK treatment guidelines online (2005)
14 September 2005. Related: Guidelines.
EMEA statement on metabolic and cardiovascular complications of antiretroviral therapy in HIV-infected patients
13 September 2005. Related: Side effects.
EMEA statement on use of antiretroviral treatment in HIV-patients with hepatic impairment and/or HBV/HCV co-infection
13 September 2005. Related: Side effects, Hepatitis coinfection.
US Preventative Services Task Force recommends screening all pregnant women for HIV
13 September 2005. Related: Pregnancy.
Volume 6 Number 9 September 2005 PDF
1 September 2005. Related: Other news.
Volume 6 Number 8 August 2005
14 August 2005. Related: Editorial.
3rd IAS Conference on HIV Pathogenesis and Treatment, 24-27 July 2005, Rio de Janeiro, Brasil
14 August 2005. Related: Conference reports.
Keystone vaccine symposia 2005: vaccines, pathogenesis, snow and a couple of elk
14 August 2005. Related: Conference reports, Vaccines and microbicides.
HIV/HCV coinfection part 1
14 August 2005. Related: Hepatitis coinfection.
Forty injured, ten shot at peaceful protest to demand treatment in South Africa
14 August 2005. Related: Treatment access.
FDA approve additional Indian generics
14 August 2005. Related: Treatment access.
Medical innovation and patent gridlock
14 August 2005. Related: Treatment access.
US adult guidelines updated – July 2005
14 August 2005. Related: Guidelines.
FDA filing of T-20 sNDA for administration with a needle-free injection device
14 August 2005. Related: Antiretrovirals.
New study urges caution over widespread criminalisation of HIV transmission
14 August 2005. Related: Other news.
Canada changes visa process for HIV-positive visitors an example for the US?
14 August 2005. Related: Other news.
Medscape full text articles
14 August 2005. Related: On the web.
Volume 6 Number 8/9 August 2005 PDF
1 August 2005. Related: PDFs.
Volume 6 Number 7 July 2005
15 July 2005. Related: Editorial.
14th International HIV Drug Resistance Workshop (14th IHDRW), 7-11 June 2005, Quebec City, Canada
15 July 2005. Related: Conference reports.
Genetic factors affecting HIV infection and progression rates: immunological factors relating to entry inhibitors
15 July 2005. Related: Conference reports, Basic science and immunology.
Resistance during MTCT strategies: new data on protective benefit of Combivir added to single-dose nevirapine, and impact of treatment and breastfeeding on the infant
15 July 2005. Related: Conference reports, Pregnancy.
Reduced replicative capacity of M184V explains benefit of 3TC monotherapy compared to stopping all drugs
14 July 2005. Related: Conference reports, Antiretrovirals.
Interaction between tenofovir and ddI in triple-nucleoside combinations: role of M184V in explaining resistance on failure
14 July 2005. Related: Conference reports, Drug resistance.
Predicting clinical responses to ddI from genotypic resistance
14 July 2005. Related: Conference reports, Drug resistance.
Under-detection of transmission of transmitted resistance and impact on treatment response
14 July 2005. Related: Conference reports, Drug resistance.
Risk of death in UK after diagnosis of 3-class resistance
14 July 2005. Related: Conference reports, Drug resistance.
Six Indian generic ARVs are given FDA tentative approval
14 July 2005. Related: Treatment access.
Methadone and buprenorphine added to WHO list of essential medicines
14 July 2005. Related: Treatment access.
MSF’s pricing guide to purchasing ARVs: 8th edition online
14 July 2005. Related: Treatment access.
WHO 3 by 5 progress report
14 July 2005. Related: Treatment access.
TMC-114 to be submitted for registration based on Phase 2b trial results: expanded access expected in UK in Autumn 2005
14 July 2005. Related: Antiretrovirals.
Tipranavir (Aptivus) approved in US
14 July 2005. Related: Antiretrovirals.
FDA fast track designation for CCR5 inhibitor vicriviroc (SCH-D)
14 July 2005. Related: Antiretrovirals.
Pfizer discontinues development of capravirine
14 July 2005. Related: Antiretrovirals.
Use of T-20 in pregnancy: case study shows transmission occurred in highly treatment experienced mother with multiple-drug resistance
14 July 2005. Related: Pregnancy.
Further reading on nevirapine resistance
14 July 2005. Related: Pregnancy.
Human Papilloma Virus vaccines a review of advances in the development of HPV vaccines
14 July 2005. Related: Vaccines and microbicides.
CDC estimate over 1 million HIV-positive people in US
14 July 2005. Related: Other news.
Newly diagnosed HIV infection – review in UK and Ireland
14 July 2005. Related: Other news.
Re-emergence of syphilis in the UK: the new epidemic phases
14 July 2005. Related: Other news.
Prescription of heroin is less costly for society
14 July 2005. Related: Other news.
Medscape full text articles
14 July 2005. Related: On the web.
HIV inSite Knowledge Base
14 July 2005. Related: On the web.
Volume 6 Number 7 July 2005 PDF
1 July 2005. Related: PDFs.
Volume 6 Number 6 June 2005
17 June 2005. Related: Editorial.
11th BHIVA and BASSH joint annual conference, 22-25 April 2005, Dublin
15 June 2005. Related: Conference reports.
Long-awaited UK pregnancy guidelines now updated; pregnancy studies in Dublin
15 June 2005. Related: Conference reports, Pregnancy.
Underdosing of ARVs in children: results from CHIPS cohort
15 June 2005. Related: Conference reports, Paediatric care.
Sexual transmission and response to treatment in acute HCV infection in HIV-positive gay men coinfected with HIV
15 June 2005. Related: Conference reports, Hepatitis coinfection.
Levels of efavirenz 10-fold above minimum target level despite coadministration with rifampicin
15 June 2005. Related: Conference reports, PK and drug interactions, Side effects.
Schistosomiasis after immune reconstitution: symptoms appear as HAART side effects
15 June 2005. Related: Conference reports, Coinfections and complications.
6th International Workshop on Clinical Pharmacology of HIV Therapy, 28-30 April 2005, Quebec, Canada
15 June 2005. Related: Conference reports.
Effect of age/menopause on lopinavir and efavirenz concentrations in women
15 June 2005. Related: Conference reports, Women's health.
Effect of age on lopinavir concentrations
15 June 2005. Related: Conference reports, Antiretrovirals.
Gender and pharmacokinetics of saquinavir
15 June 2005. Related: Conference reports, Antiretrovirals.
Dosing nevirapine in children
15 June 2005. Related: Conference reports, Paediatric care.
Intracellular NRTI-triphosphate levels in children are similar to adults
15 June 2005. Related: Conference reports, Paediatric care.
Efavirenz and rifampicin: lower body weight associated with higher concentrations
15 June 2005. Related: Conference reports, TB coinfection.
Summary of drug-drug interaction studies
15 June 2005. Related: Conference reports, PK and drug interactions.
Responses to atazanavir, Kaletra and side effects
15 June 2005. Related: Conference reports, Antiretrovirals.
MSF criticises Brazilian government for failing to break antiretroviral patents
15 June 2005. Related: Treatment access.
Russian activists imprisoned for asking for treatment – letters of support requested
15 June 2005. Related: Treatment access.